Castle Biosciences, Inc. · NASDAQ:CSTL

Oelschlager Kristen M sold 8,586 Castle Biosciences, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 6, 2026

On Jul 1, 2026, Oelschlager Kristen M (Chief Operating Officer) sold 8,586 Castle Biosciences, Inc. shares at an average US$24.42 for US$210K under a trading plan, leaving 21,874 shares. Filed Jul 6, 2026 (Form 4).

Sold
8,586 shares
Price
US$24.42 average (US$24.40 to US$24.78)
Value
US$210K
Holding after
21,874 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common StockSale8,186US$24.4022,274Direct
Jul 1, 2026Common StockSale400US$24.7821,874Direct

Source

View original at SEC

Related